Parwinder Purewal
Oncology Pharmacist · Santa Rosa, CA
Parwinder Purewal is an oncology pharmacist with a practice address in Santa Rosa, California, and NPI 1962136598, issued on Jul 11, 2022. Check the license (California 82705, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Parwinder Purewal
- Primary taxonomy
- Oncology Pharmacist 1835X0200X
- License number
- 82705 CA
Self-reported in NPPES; status is on the state search - Practice location
- 3555 Round Barn Circle, Santa Rosa, CA 95403
- Phone
- (707) 521-3891
- Enumerated
- Jul 11, 2022
- Record last updated
- Jul 11, 2022
- Entity
- Type 1 · individual
Also registered at 3555 Round Barn Circle
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Frederick David, M.D.Radiation Oncology Physician1982793808
Verify Parwinder Purewal in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich California board licenses this profession
Search for license 82705Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
77% more Medicare Part D claims than the average oncology pharmacist in 2024
313 Medicare Part D claims for 76 beneficiaries, against an average of 177 among the 69 providers of this specialty who prescribed in Part D. Brand-name drugs were 48% of claims.
Most prescribed
- Abiraterone Acetate51 claims
- Nubeqa37 claims
- Prochlorperazine Maleate22 claims
- Brukinsa19 claims
- Prednisone18 claims
- Lenalidomide17 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Oncology Pharmacist providers in California
There are 287 oncology pharmacist records in California.
Other oncology pharmacist records in California
- Aseala Abousaud, PHARMD, BCOP, APHWalnut Creek, CA1396611869
- Jayrom Acorda, PHARM.D.Palm Springs, CA1497441240
- Antonio Acuna, PHARMDSan Diego, CA1629959408
- Leena Agrawal, PHARMDSanta Rosa, CA1174221634
- Artemio Alanis, PHARMDFairfield, CA1396513982
- Prasannaraddi Alavandi, PHARMDPalo Alto, CA1932035482
- Maher Alhaja, PHARMDSan Diego, CA1104515964
- Nigina Ali, PHARM.D.Martinez, CA1760022545
- Linda AllworthPalo Alto, CA1538035969
- Eleonora Amcheslavsky, PHARMDGreenbrae, CA1992115729
Common questions
What is Parwinder Purewal's NPI number?
Parwinder Purewal's National Provider Identifier (NPI) is 1962136598, issued on Jul 11, 2022. An NPI identifies a provider in billing; it is not a license.
Where is Parwinder Purewal located?
The NPPES record lists a practice address at 3555 Round Barn Circle, Santa Rosa, CA, 95403. Phone: (707) 521-3891. Providers update this record themselves, so call before visiting.
How can I verify Parwinder Purewal's license?
NPPES lists California license number 82705, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.
How much does Parwinder Purewal prescribe under Medicare Part D?
In 2024, Parwinder Purewal had 313 Medicare Part D claims for 76 beneficiaries; the average among oncology pharmacist prescribers was 177. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.